2nd International Conference on Fostering Interdisciplinary Research In Health Sciences (ICFIRHS) 2019 (01-May-2019)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   6

Issue No. :  2

Year :  2013

Pages :   158-161

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Registration

Allready Registrered
Click to Login

Development and Validation of Stability Indicating HPTLC Method for Determination of Repaglinide



Address:   Kiran Deshpande, Pranjali Ranaware, A. R. Madgulkar, M.C. Damle*
Department of Pharmaceutical Chemistry, AISSMS College of Pharmacy, Kennedy road, Near R.T.O
*Corresponding Author
DOI No: Not Available

ABSTRACT:
Repaglinide is a widely used meglitinide class drug to treat diabetes. The current study describes degradation as per ICH guidelines (hydrolysis, photolysis, dry heat and oxidation) and optimized assay method. A simple stability indicating method has been developed for Repaglinide in bulk drug. The peak purity of the drug was observed. For HPTLC study Aluminium plates precoated with Silica Gel 60 F254 was the stationary phase and mobile phase consisted of methanol: toluene (2:8 ) and quantitation was done at the wavelength 242nm. The method was found to be simple, specific, precise and stability indicating.
KEYWORDS:
Repaglinide, ICH guidelines, Stress degradation, Validation and Stability indicating method.
Cite:
Kiran Deshpande, Pranjali Ranaware, A. R. Madgulkar, M.C. Damle. Development and Validation of Stability Indicating HPTLC Method for Determination of Repaglinide. Research J. Pharm. and Tech. 6(2): Feb. 2013; Page 158-161.
[View HTML]      [View PDF]



Visitor's No. :   640499